These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 16478629

  • 1. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
    Kawase S, Okuda T, Ikeda M, Ishihara S, Itoh Y, Yanagawa S, Ishigaki T.
    Gynecol Oncol; 2006 Sep; 102(3):493-9. PubMed ID: 16478629
    [Abstract] [Full Text] [Related]

  • 2. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S, Ogasawara T, Tsubamoto H, Oku H, Hori Y, Tsuji Y, Takemura T, Koyama K.
    Int J Clin Pharmacol Res; 2001 Sep; 21(3-4):105-10. PubMed ID: 12067139
    [Abstract] [Full Text] [Related]

  • 3. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP.
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO, Kim GE.
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [Abstract] [Full Text] [Related]

  • 6. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
    Onishi H, Yamaguchi M, Kuriyama K, Tsukamoto T, Ishigame K, Ichikawa T, Aoki S, Yoshikawa T, Araki T, Nambu A, Araki T, Hashi A, Yasumizu T, Hoshi K, Ito H.
    Cancer J Sci Am; 2000 Jan; 6(1):40-5. PubMed ID: 10696738
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
    Yamakawa Y, Fujimura M, Hidaka T, Hori S, Saito S.
    Gynecol Oncol; 2000 May; 77(2):264-70. PubMed ID: 10785476
    [Abstract] [Full Text] [Related]

  • 8. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yang SN, Lin FJ.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1370-7. PubMed ID: 16979836
    [Abstract] [Full Text] [Related]

  • 9. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 10. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M, Martínez-Monge R, García-Foncillas J, Azinovic I, Aristu J, López-García G, Brugarolas A.
    Gynecol Oncol; 1999 Jul 01; 74(1):30-7. PubMed ID: 10385548
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF, Tseng CJ, Tseng CC, Yu CY, Wu CT, Chen WC.
    Cancer J; 2008 Jul 01; 14(3):200-6. PubMed ID: 18536561
    [Abstract] [Full Text] [Related]

  • 12. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 13. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T, Nishida T, Hasuo Y, Fujiyoshi K, Yakushiji M.
    Gynecol Oncol; 1998 May 01; 69(2):130-6. PubMed ID: 9600820
    [Abstract] [Full Text] [Related]

  • 14. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
    Stehman FB, Bundy BN, Kucera PR, Deppe G, Reddy S, O'Connor DM.
    Gynecol Oncol; 1997 Aug 01; 66(2):262-7. PubMed ID: 9264574
    [Abstract] [Full Text] [Related]

  • 15. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, Monk BJ, O'Connor DM.
    J Clin Oncol; 2005 Nov 20; 23(33):8289-95. PubMed ID: 16230678
    [Abstract] [Full Text] [Related]

  • 16. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.
    Mabuchi S, Morishige K, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T, Yoshino K, Enomoto T, Inoue T, Kimura T.
    Gynecol Oncol; 2009 Dec 20; 115(3):482-7. PubMed ID: 19783286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa-IVa cervical cancer.
    Motoyama S, Hamana S, Ku Y, Laoag-Fernandez JB, Deguchi M, Yoshida S, Tominaga M, Iwasaki T, Ohara N, Maruo T.
    Gynecol Oncol; 2004 Dec 20; 95(3):576-82. PubMed ID: 15581966
    [Abstract] [Full Text] [Related]

  • 20. Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study.
    Viegas CM, Araujo CM, Dantas MA, Froimtchuk M, Oliveira JA, Marchiori E, Souhami L.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1154-9. PubMed ID: 15519787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.